Therapeutic Confirmatory (Phase III)

3,259 trials 1,319 recruiting

Filter these 3,259 trials by condition, country, sponsor and more.

Open in Search →

A Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination with Cabozantinib Versus Cabozantinib Alone in Patients wit… Ended

2024-517785-42-00 Renal cell carcinoma (RCC) 2020-10-08
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and N… Ended

2022-501987-16-00 Metastatic nonsquamous or squamous non-small cell lung 2020-10-02
Personalized Vitamin D Supplementation for Reducing or Preventing Fatigue and Enhancing Quality of Life of Patients with Colorectal Tumor: R… Ended

2024-515420-37-01 Fatigue in patients with colorectal cancer (CRC) (ICD c 2020-09-28
Study to assess the efficacy and safety of alpelisib (BYL719) in combination with trastuzumab and pertuzumab as maintenance therapy in patie… Ended

2024-512050-13-00 HER2-positive advanced breast cancer 2020-09-22
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cel… Ended

2022-502480-38-00 Non−small cell lung cancer (NSCLC) 2020-09-09
SAR408701 versus docetaxel in previously treated, carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) positive metastatic no… Ended

2024-515101-26-00 Non-small cell lung cancer metastatic 2020-08-21
Double-blind (neither the patient nor the doctor knows treatment allocation of the patient), randomized, placebo-controlled, prospective pha… Ended

2023-509737-39-00 Primary infection prophylaxis in patients with chronic 2020-08-19
Clinical trial to assess the efficacy and safety of a vaccine for dust mite allergy Ended

2024-514090-21-00 Aetiological treatment of moderate - severe intermitten 2020-08-05
An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS transitioning from fumarate-based RMS approv… Ended

2023-507493-41-00 relapsing multiple sclerosis (RMS) 2020-08-04
Open Label 2-Arm Study of Venetoclax in Combination with Azacitidine Versus Best Supportive Care after Allogeneic Stem Cell Transplantation … Ended

2023-507222-17-00 Acute Myeloid Leukaemia 2020-07-24
Phase 3 Study of Pembrolizumab and Lenvatinib in Combination with TACE for Incurable/Non-metastatic Hepatocellular Carcinoma Ended

2022-502116-36-00 Incurable/Non-metastatic Hepatocellular Carcinoma 2020-07-10
Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGROLT) Ended

2023-509801-59-00 Alopecia areata 2020-07-09
An extension study to learn if Bimekizumab works and is safe over a long period in adults with Active Axial Spondyloarthritis. Ended

2023-506527-28-00 Axial Spondyloarthritis 2020-06-29
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) Ended

2023-506873-36-00 Frontotemporal dementia (FTD) 2020-06-29
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of emicizumab in patients with mild or moderate hemophilia A… Ended

2023-506610-52-00 Mild or moderate hemophilia A without FVIII inhibitors 2020-06-24
A Study of Atezolizumab plus Carboplatin and Etoposide with or Without Tiragolumab (Anti-Tigit Antibody) in Patients with Untreated Extensiv… Ended

2022-502988-37-00 Small cell lung cancer (SCLC) 2020-06-19
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV… Ended

2023-507846-96-00 Type 2 Diabetes Mellitus 2020-06-19
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (AcceleRET-Lung) Ended

2023-505035-12-00 RET fusion−positive, metastatic Non-Small Cell Lung Can 2020-06-12
Study on prevention of respiratory consequances related to bronchiolotis caused by respiratory sincizial virus (RSV) in preterm babies Ended

2024-515418-41-00 Respiratory sincizial (RSV) bronchiolitis 2020-06-12
Multicenter, Phase 3 Study of Venetoclax and Azacitidine as Maintenance Therapy for Patients with Acute Myeloid Leukemia in First Remission … Ended

2023-507221-42-00 Acute Myeloid Leukemia in First Remission 2020-06-03
Long-term Study of Apremilast (CC-10004) in Pediatric Subjects from 6 Through 17 Years of Age with Moderate to Severe Plaque Psoriasis Ended

2023-503600-83-00 Moderate to Severe Plaque Psoriasis 2020-05-27
Study to compare 2 chemotherapy, one with Irinotecan liposome injection in addition to combination of chemotherapy and one with standard che… Ended

2024-518303-21-00 Metastatic Pancreatic Adenocarcinoma 2020-05-25
A Study of Tiragolumab, an Anti-TIGIT Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab (an … Ended

2022-502482-17-00 Non-small cell lung cancer (NSCLC) 2020-05-19
A Phase 3 Study of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in AdultsUndergoin… Ended

2024-514471-18-00 Invasive Fungal Diseases in Adults undergoing Allogenei 2020-05-13